Knowledge Center
The first deadline for the RxDC reporting requirement on calendar years 2020 and 2021 is December 27, 2022. The Departments have issued FAQ Part 56 addressing this requirement.
Regulations were recently finalized fixing the “family glitch” and expanding Marketplace premium tax credits for employees’ family members when employer-sponsored coverage is not affordable. A new
Employers sponsoring a group health plan must report information on the creditable (or non-creditable) status of the plan’s prescription drug coverage to the Centers for Medicare and Medicaid
The Biden Administration announced its intent to end the Public Health Emergency and the National Emergency related to the COVID-19 pandemic on May 11, 2023. Various employee benefit plan
The Department of Labor has published the annual adjustments for 2023 that increase certain penalties applicable to employee benefit plans.
The Secretary of Health and Human Services has again renewed the COVID-19 pandemic Public Health Emergency. This will extend the Public Health Emergency Period for an additional 90 days and as a
As previously reported in 2021, plan sponsors of group health plans are required to submit information annually about prescription drugs and health care spending to the Centers fo Medicare and
President Biden recently signed the “Inflation Reduction Act” into law, which includes key health care, tax, and climate change components.
Ask the Experts - July 2022, Podcast
The Patient-Centered Outcomes Research fee filing deadline is August 1, 2022, for all self-funded medical plans and HRAs for plan years ending in 2021.
Our Advisors offer in-depth analysis and are ready to help you successfully navigate employee benefits and health insurance.
Our website uses cookies. Click here to view our privacy policy.